MENLO PARK, Calif.--(BUSINESS WIRE)--Notogen Inc., a biotechnology company developing regenerative therapeutics for conditions related to spinal degeneration, orthopedics and sports medicine, ...
The Phase 3 study is a global trial to evaluate improvements in both pain and function for up to 12 months following a MOTYS ...
Two-part preclincal and clinical development programme launched to assess potential benefits of administering S-pindolol benzoate during and post-GLP-1 receptor agonist therapy to improve muscle mass, ...
The UCI has announced the provisional suspension of Dutch climber Antwan Tolhoek following a positive test for anabolic androgenic steroids in an out-of-competition test last November. 29-year-old ...
Two new composition of matter patents granted in the US and Europe Patents provide protection relating to lead compound S-pindolol benzoate (ACM-001.1), significantly strengthening company’s ...
Two-part clinical study programme to evaluate change in lean and fat mass in patients receiving two different doses of S-pindolol benzoate whilst 1) receiving the GLP-1 agonist semaglutide; and 2) ...
GENEVA (AP) — Two-time Olympic finalist Erriyon Knighton was banned for four years on Friday in a doping case that ruled the 21-year-old United States sprinter out of the 2028 Los Angeles Games. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback